TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
111.55
-3.41 (-2.97%)
At close: Sep 2, 2025, 4:00 PM
112.00
+0.45 (0.40%)
After-hours: Sep 2, 2025, 7:46 PM EDT
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $3.80 billion as of September 2, 2025. Its market cap has decreased by -30.10% in one year.
Market Cap
3.80B
Enterprise Value
3.92B
1-Year Change
-30.10%
Ranking
Category
Stock Price
$111.55
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $3.80B, an increase of 740.43%. That is a compound annual growth rate of 39.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 3.92B | 87.28% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | 540.50M | 34.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |